L J Nannini
Overview
Explore the profile of L J Nannini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
125
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nannini L, Neumayer N, Brandan N, Fernandez O, Flores D
Eur Clin Respir J
. 2022 Aug;
9(1):2110706.
PMID: 35959199
Overreliance on short-acting β-agonists (SABA) has been a common feature of asthma management globally for at least 30 years. However, given the evidence against the long-term use of SABA, including...
2.
Nannini L, Luhning S, Rojas R, Antunez J, Miguel Reyes J, Cano Salas C, et al.
J Asthma
. 2020 Jun;
58(8):991-994.
PMID: 32482150
In Latin-America, with 603 million inhabitants, the average prevalence of asthma is estimated at 17%, but with wide fluctuations, ranging from 5% in some cities (Mexico) to 30% in Costa...
3.
Nannini L, Quintana R, Bagilet D, Druetta M, Ramirez M, Nieto R, et al.
Med Intensiva
. 2012 Nov;
37(9):593-9.
PMID: 23158868
Objectives: In this prospective clinical trial we aimed to answer if spontaneous exhaled breath condensate (EBC) in the trap of the expiratory arm of the ventilator could replace EBC collected...
4.
Nannini L, Cates C, Lasserson T, Poole P
Cochrane Database Syst Rev
. 2007 Oct;
(4):CD006829.
PMID: 17943918
Background: The co-administration of inhaled corticosteroids and long-acting beta-agonists in a combined inhaler is intended to facilitate adherence to medication regimens, and to improve efficacy in COPD. In this review...
5.
Nannini L, Cates C, Lasserson T, Poole P
Cochrane Database Syst Rev
. 2007 Oct;
(4):CD006826.
PMID: 17943917
Background: Long-acting beta-agonists and inhaled corticosteroids have both been recommended in guidelines for the treatment of chronic obstructive pulmonary disease. Their co-administration in a combined inhaler is intended to facilitate...
6.
Nannini L, Zaietta G, Guerrera A, Varela J, Fernandez O, Flores D
Respir Med
. 2006 Jul;
101(2):246-53.
PMID: 16824744
Rationale: Identification of asthmatic subjects with low perception of dyspnea (POD) that are at higher risk of hospitalization, near-fatal and fatal asthma could improve their management. Objective: Create a simple...
7.
Rodrigo G, Rodrigo C, Nannini L
Arch Bronconeumol
. 2004 Jan;
40(1):24-33.
PMID: 14718118
No abstract available.
8.
Nannini L
Medicina (B Aires)
. 2001 Jul;
61(3):262-6.
PMID: 11474870
Ipratropium bromide (IB), a quaternary derivative of atropine has been extensively recommended as the first bronchodilator to be tried in chronic obstructive pulmonary disease (COPD). Despite the large information concerning...
9.
Pendino J, Nannini L, Chapman K, Slutsky A, Molfino N
J Asthma
. 1998 Mar;
35(1):89-93.
PMID: 9513587
We assessed the acute bronchodilator effect of nebulized furosemide when added to conventional therapy of acute emergency department (ED) asthma. Using a double-blind design, 42 patients with acute asthma were...
10.